arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

SERA PROGNOSTICS, INC.

SERA
$2.09 ▼ -0.02 (-0.95%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
27 Visible periods
24 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

SERA PROGNOSTICS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $105.5M
Dividend Yield
Revenue Growth 76.5%
Op. Margin
ROIC -13.3%
FCF / Share $-0.13
Trailing P/E
Price / Book 1.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$30.00K
↑ +76.5%
Net Income Profit after all expenses
$-8.40M
↓ -2.6%
FCF / Share Free cash flow per share
$-0.13
↑ +28.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
19
Financial Health
2
Cash Quality
56

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters